Our study indicates that the biophysical effects produced by UTMD have great potential to enhance the acquired immunity in the advanced tumor, and the UTMD and PDL-1/PD-1 blockade combination therapy provides an option to overcome the challenges of immunotherapy that cancer patients are currently facing. This evidence concerns the gene CD274 and cancer.